arrow
R

Rui Xiong

University of Arizona
H指数:25
被引数:1,917

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Mixed Lineage Kinase Suppression in Triple-Negative Breast Cancer: Identification of a Dual Inhibitor Targeting MLK3 and NAMPT

三阴性乳腺癌中混合谱系激酶的抑制:鉴定靶向MLK3和NAMPT的双靶点抑制剂

2026-06-100
PRE
Discovery of the SARS-CoV-2 Papain-Like Protease Inhibitor MR1–114: From Structure-Based Design to In Vivo Antiviral Efficacy

SARS-CoV-2半胱氨酸蛋白酶抑制剂MR1–114的发现:从基于结构的药物设计到体内抗病毒功效

2026-03-260
OA
Online risk scores for pre- and postoperative prediction of early recurrence in hepatocellular carcinoma patients undergoing conversion liver resection after tyrosine kinase inhibitors and immune checkpoint inhibitors therapy

行转化性肝切除的肝细胞癌患者经酪氨酸激酶抑制剂和免疫检查点抑制剂治疗后,用于术前和术后早期复发的在线风险评分

2025-06-160
PRE
Whole genome sequencing revealed genetic structure, domestication, and selection of Chinese indigenous ducks

全基因组测序揭示了中华本土鸭的遗传结构、驯化与选择。

2025-05-010
PRE
Non-Covalent Inhibitors of SARS-CoV-2 Papain-Like Protease (PLpro): In Vitro and In Vivo Antiviral Activity

SARS-CoV-2木瓜蛋白酶样蛋白酶 (PLpro) 的非共价抑制剂: 体外和体内抗病毒活性

2024-08-051
OAAI
XP-524 is a dual-BET/EP300 inhibitor that represses oncogenic KRAS and potentiates immune checkpoint inhibition in pancreatic cancer

XP-524是一种双重BET/EP300抑制剂,可抑制致癌KRAS并增强胰腺癌的免疫检查点抑制

2022-01-2125
OAAI